{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:47:53Z","timestamp":1788997673174,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>We aimed to demonstrate the distribution of alcohol use disorder (AUD) in China and assess its association with quality of life and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We studied 367 120 men aged 35\u201375\u00a0years from 31 provinces in the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project. At baseline, AUD was assessed by alcohol use disorders identification test score, and EQ-5D-3L questionnaire was used to measure the quality of life. Mortality data was collected via National Mortality Surveillance System and Vital Registration. Mixed models were fitted to assess the associations of AUD with quality of life, and Cox proportional hazard models were fitted for the associations with all-cause and cause-specific mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 39 163 men with AUD, which accounted for 10.7% of male participants and 25.8% of male drinkers. In the multivariable analysis, male drinkers who were aged 45\u201354\u00a0years, with higher education level, currently smoking, obese, with diagnosed hypertension, and without diagnosed cardiovascular diseases had higher rates of AUD. Male drinkers with AUD were less likely to have optimal QOL compared with those without AUD (OR: 0.63, 95% CI: 0.61\u20130.65, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Moreover, among male drinkers, AUD was prospectively associated with a 20% higher risk for all-cause mortality and a 30% higher risk for mortality from cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In China one fourth of men who drank alcohol had AUD, which was associated with lower QOL and higher risk of all-cause mortality. National policies or strategies are urgently needed to control alcohol-related harms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13146-4","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T19:15:40Z","timestamp":1650395740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Alcohol use disorder and its association with quality of life and mortality in Chinese male adults: a population-based cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiapeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"issue":"10159","key":"13146_CR1","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"JD Stanaway","year":"2018","unstructured":"Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1923\u201394.","journal-title":"The Lancet"},{"issue":"2","key":"13146_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD. Global Burden of Disease and the Impact of Mental and Addictive Disorders. Curr Psychiatry Rep. 2019;21(2):10.","journal-title":"Curr Psychiatry Rep"},{"key":"13146_CR3","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.addbeh.2019.106128","volume":"102","author":"MD Glantz","year":"2020","unstructured":"Glantz MD, Bharat C, Degenhardt L, Sampson NA, Scott KM, Lim CCW, et al. The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys. Addictive behaviors. 2020;102:106128.","journal-title":"Addictive behaviors."},{"issue":"5","key":"13146_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/add.12876","volume":"110","author":"HG Cheng","year":"2015","unstructured":"Cheng HG, Deng F, Xiong W, Phillips MR. Prevalence of alcohol use disorders in mainland China: a systematic review. Addiction. 2015;110(5):761\u201374.","journal-title":"Addiction"},{"issue":"10","key":"13146_CR5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1111\/j.1530-0277.2009.01014.x","volume":"33","author":"L Zhou","year":"2009","unstructured":"Zhou L, Conner KR, Phillips MR, Caine ED, Xiao S, Zhang R, et al. Epidemiology of alcohol abuse and dependence in rural chinese men. Alcohol Clin Exp Res. 2009;33(10):1770\u20136.","journal-title":"Alcohol Clin Exp Res"},{"key":"13146_CR6","doi-asserted-by":"crossref","unstructured":"Im PK, Millwood IY, Chen Y, Guo Y, Du H, Kartsonaki C, et al. Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank. Addiction. 2020;115(5):850-62.","DOI":"10.1111\/add.14873"},{"key":"13146_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2016.12.026","volume":"173","author":"MR Phillips","year":"2017","unstructured":"Phillips MR, Cheng HG, Li X, Zhang J, Shi Q, Xu G, et al. Prevalence, correlates, comorbidity, and age of onset of alcohol use disorders in adult males from five provinces in China. Drug Alcohol Depend. 2017;173:170\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"13146_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12889-019-6502-1","volume":"19","author":"PK Im","year":"2019","unstructured":"Im PK, Millwood IY, Guo Y, Du H, Chen Y, Bian Z, et al. Patterns and trends of alcohol consumption in rural and urban areas of China: findings from the China Kadoorie Biobank. BMC Public Health. 2019;19(1):217.","journal-title":"BMC Public Health"},{"issue":"4","key":"13146_CR9","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/S2214-109X(15)70017-3","volume":"3","author":"H Jiang","year":"2015","unstructured":"Jiang H, Room R, Hao W. Alcohol and related health issues in China: action needed. Lancet Glob Health. 2015;3(4):e190\u20131.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"13146_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/add.12231","volume":"108","author":"M Roerecke","year":"2013","unstructured":"Roerecke M, Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction. 2013;108(9):1562\u201378.","journal-title":"Addiction"},{"issue":"9","key":"13146_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jech-2017-210078","volume":"72","author":"S Kuitunen-Paul","year":"2018","unstructured":"Kuitunen-Paul S, Roerecke M. Alcohol Use Disorders Identification Test (AUDIT) and mortality risk: a systematic review and meta-analysis. J Epidemiol Community Health. 2018;72(9):856\u201363.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"13146_CR12","doi-asserted-by":"publisher","first-page":"e010200","DOI":"10.1136\/bmjopen-2015-010200","volume":"6","author":"J Lu","year":"2016","unstructured":"Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, et al. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ open. 2016;6(1):e010200.","journal-title":"BMJ open."},{"key":"13146_CR13","unstructured":"World Health Organization. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care (second edition). https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/67205\/WHO_MSD_MSB_01.6a.pdf;jsessionid=0D4AF932CC6C030FEAA0F6D39A7F4EFE?sequence=1 (Accessed date: 26 March 2020)."},{"issue":"1","key":"13146_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12889-019-6831-0","volume":"19","author":"W Lu","year":"2019","unstructured":"Lu W, Xu J, Taylor AW, Bewick BM, Fu Z, Wu N, et al. Analysis of the alcohol drinking behavior and influencing factors among emerging adults and young adults: a cross-sectional study in Wuhan, China. BMC Public Health. 2019;19(1):458.","journal-title":"BMC Public Health"},{"issue":"4","key":"13146_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/alcalc\/agr012","volume":"46","author":"Q Li","year":"2011","unstructured":"Li Q, Babor TF, Hao W, Chen X. The Chinese translations of Alcohol Use Disorders Identification Test (AUDIT) in China: a systematic review. Alcohol Alcohol. 2011;46(4):416\u201323.","journal-title":"Alcohol Alcohol"},{"key":"13146_CR16","doi-asserted-by":"crossref","unstructured":"Wang H, Kindig DA, Mullahy J. Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Quality of life research\u202f: an international journal of quality of life aspects of treatment, care and rehabilitation. 2005;14(1):119\u201332.","DOI":"10.1007\/s11136-004-0612-6"},{"key":"13146_CR17","doi-asserted-by":"crossref","unstructured":"Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value in health\u202f: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014;17(5):597\u2013604.","DOI":"10.1016\/j.jval.2014.05.007"},{"key":"13146_CR18","first-page":"1","volume-title":"Statistical Power Analysis for the Behavioral Sciences (2nd edition)","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edition). Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. p. 1\u201317."},{"issue":"4","key":"13146_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika. 1934;26(4):404\u201313.","journal-title":"Biometrika"},{"issue":"8","key":"13146_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","volume":"72","author":"BF Grant","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, et al. Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiat. 2015;72(8):757\u201366.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"13146_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/ije\/dyt078","volume":"42","author":"IY Millwood","year":"2013","unstructured":"Millwood IY, Li L, Smith M, Guo Y, Yang L, Bian Z, et al. Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. International journal of epidemiology. 2013;42(3):816\u201327.","journal-title":"International journal of epidemiology"},{"issue":"8","key":"13146_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1360-0443.2009.02595.x","volume":"104","author":"S Lee","year":"2009","unstructured":"Lee S, Guo WJ, Tsang A, He YL, Huang YQ, Zhang MY, et al. Associations of cohort and socio-demographic correlates with transitions from alcohol use to disorders and remission in metropolitan China. Addiction. 2009;104(8):1313\u201323.","journal-title":"Addiction"},{"issue":"9680","key":"13146_CR23","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(09)60660-7","volume":"373","author":"MR Phillips","year":"2009","unstructured":"Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001\u201305: an epidemiological survey. Lancet. 2009;373(9680):2041\u201353.","journal-title":"Lancet"},{"issue":"6","key":"13146_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamapsychiatry.2016.0360","volume":"73","author":"KS Kendler","year":"2016","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Alcohol Use Disorder and Mortality Across the Lifespan: A Longitudinal Cohort and Co-relative Analysis. JAMA Psychiat. 2016;73(6):575\u201381.","journal-title":"JAMA Psychiat"},{"key":"13146_CR25","unstructured":"Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol research\u202f: current reviews. 2012;34(4):414\u201331."},{"key":"13146_CR26","unstructured":"World Health Organization. Global status report on alcohol and health 2018. Geneva. 2018. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/9789241565639. Accessed 19 Apr 2020."},{"issue":"2","key":"13146_CR27","first-page":"CD004148","volume":"2","author":"EF Kaner","year":"2018","unstructured":"Kaner EF, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018;2(2):CD004148.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"13146_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12888-019-2011-0","volume":"19","author":"F Jiang","year":"2019","unstructured":"Jiang F, Rakofsky J, Zhou H, Hu L, Liu T, Wu S, et al. Satisfaction of psychiatric inpatients in China: clinical and institutional correlates in a national sample. BMC Psychiatry. 2019;19(1):19.","journal-title":"BMC Psychiatry"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13146-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T18:02:55Z","timestamp":1650477775000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13146"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13146-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The central ethics committee at the China National Center for Cardiovascular Disease approved this project. All enrolled participants provided written informed consent. And all methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Jing Li reported receiving research grants, through Fuwai Hospital, from Chinese government and Chinese Academy of Medical Sciences for work to improve the management of hypertension and blood lipids and to improve patient outcomes of cardiovascular disease and COVID-19; receiving research agreements, through the National Center for Cardiovascular Diseases and Fuwai Hospital, from Amgen for a multicenter clinical trial assessing the efficacy and safety of omecamtiv mecarbil and for dyslipidemic patient registration; receiving a research agreement, through Fuwai Hospital, from Sanofi for a multicenter clinical trial on the effects of sotagliflozin; receiving a research agreement, through Fuwai Hospital, with the University of Oxford for a multicenter clinical trial of empagliflozin; receiving a research agreement, through the National Center for Cardiovascular Diseases, from AstraZeneca for clinical research methods training outside the submitted work; and receiving a research agreement, through the National Center for Cardiovascular Diseases, from Lilly for physician training outside the submitted work. No other disclosures were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"789"}}